Melts and Messes: Medical and surgical approaches to corneal disasters

My Session Status

Kiedy:

10:45, sobota 2 cze 2018 (1 godz. 30 min.)

Przerwy:

Lunch 12:15 PO POŁUDNIU do 01:30 PO POŁUDNIU (1 godz. 15 min.)

Gdzie:

Metro Toronto Convention Centre (South Building) - Room 714 A

Ścieżka:

Cornea

LEARNING OBJECTIVES
At the end of this session, participants will be able to:

Describe medical management of severe corneal disease
Describe surgical management of severe corneal disease

CANMEDS ROLES: Medical Expert, Scholar

Setareh Ziai

Moderator

Dr. Mahshad Darvish

Other Participant

Sonia N. Yeung, MD, PhD, FRCSC

Other Participant

Elementy podrzędne

Introduction

10:45 - 10:47 | 2 min.

Besifloxacin ophthalmic suspension in patients with bacterial keratitis: A prospective, randomized clinical study

10:47 - 10:52 | 5 min.

Ron Jans Clinical Cornea Research AwardAward Winner

RON JANS CLINICAL CORNEA RESEARCH AWARD WINNER Authors: Fatma Zaguia, Michael Ross, Mahshad Darvish, Jean DeschênesAuthor Disclosure Block: F. Zaguia: None. M. Ross: None. M. Darvish: Allergan, Johnson & Johnson, Santen, Shire. J. Deschênes: AbbVie, Allergan, Imprimis, NIE/NEI, Santen. Shire.Abstract Body: Purpose: Bacterial keratitis is a serious ocular problem that can, if not appropriately treated, lead ...